GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
Through lifestyle modifications, ADORE will assess the progress of patients based on parameters like reduction in blood sugar levels and weight, among others
40,000 visitors and representatives of more than 80 countries set to visit the show
Subscribe To Our Newsletter & Stay Updated